Blog

We have added a new clinical trial to our roster of brain tumor trials at the Pacific Neuroscience Research Center at PNI. NEW CLINICAL TRIAL Orbus Therapeutics (NCT02796261): A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine With Lomustine Compared to Lomustine...

If this is the first time you are hearing that November is National Family Caregivers Month, you are not alone. Many Americans, including professional healthcare providers, are not aware that there is a month designated to promoting national recognition of family caregivers. President Clinton signed...

We have recently added a new clinical trial protocol at the Pacific Neuroscience Research Center at PNI. NEW CLINICAL TRIAL Boehringer Ingelheim (NCT 02423525): A Phase I Dose Escalation and CNS Pharmacokinetic Study of the ErbB Family Inhibitor Afatinib in Patients with Recurrent or Progressive Brain...

Read about Dr. Barkhoudarian, Co-Director of the Pacific Pituitary Disorders Center and Director of the Pacific Adult Hydrocephalus and Facial Pain Centers.

We have a number of ongoing and new clinical trials at the Pacific Brain Tumor Center for patients who may benefit from newer brain tumor treatment options. In our Clinical Trials Round-Up blog series, we will periodically provide an update on the latest clinical trials and studies at our center....

We are very excited to announce the launch of the new Pacific Neuroscience Institute website, www.PacificNeuro.org Since 2007, the Pacific Brain Tumor Center & Pituitary Disorders Program has been focused on providing comprehensive care and minimally invasive treatment of brain, skull base and pituitary tumors.  Over...

We are at a point in medicine where in the near future many types of cancers will be in long-term remission and will even achieve the tentative status of being cured. Funding at the national level for Precision Medicine programs, including cancer, is dramatically helping to achieve...

Providence Saint John’s Health Center has opened the first Voyager device clinical trial in Los Angeles. Principal investigator, Garni Barkhoudarian, MD, and co- investigator, Santosh Kesari, MD, PhD, both faculty at Saint John’s Cancer Institute and Pacific Neuroscience Institute physicians, are actively recruiting patients for...

As a youngster, Santosh Kesari, MD, PhD, often wondered: “Who are we?” That philosophical question sparked his curiosity about the brain and, later, the brain-body connection. Today that fascination has evolved into a full-blown passion that’s led him to become one of the foremost neuro-oncologists...

Crossing the blood-brain barrier can be a good thing. The blood-barrier normally protects the brain from attack by toxins and infection. This same protective quality prevents drugs reaching areas of the brain that are affected by disease such as brain cancer. Researchers in Canada were able...